 |
|
Intensity of statin therapy and renal outcome in chronic kidney disease: Results from the Korean Cohort Study for Outcome in Patients With Chronic Kidney Disease
Jong Hyun Jhee, Young Su Joo, Jung Tak Park, Tae-Hyun Yoo, Sue Kyung Park, Ji Yong Jung, Soo Wan Kim, Yun Kyu Oh, Kook-Hwan Oh, Shin-Wook Kang, Kyu Hun Choi, Curie Ahn, Seung Hyeok Han
Kidney Res Clin Pract. 2020;39(1):93-102. Published online 2020 Mar 31 DOI: https://doi.org/10.23876/j.krcp.20.007
|
|
Citations to this article as recorded by
 Anti-fibrotic effects of statin drugs: A review of evidence and mechanisms
David M. Dolivo, Charlotte R. Reed, Kristine A. Gargiulo, Adrian E. Rodrigues, Robert D. Galiano, Thomas A. Mustoe, Seok Jong Hong
Biochemical Pharmacology.2023; 214: 115644. CrossRef Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview
Sang Heon Suh, Soo Wan Kim
Diabetes & Metabolism Journal.2023; 47(5): 612. CrossRef Comparative analysis of potential drug-drug interactions in a public and private hospital among chronic kidney disease patients in Khyber Pakhtunkhwa: A retrospective cross-sectional study
Roheena Zafar, Inayat Ur Rehman, Yasar Shah, Long Chiau Ming, Hui Poh Goh, Khang Wen Goh, Muhammad Junaid Farrukh
PLOS ONE.2023; 18(9): e0291417. CrossRef Low-density lipoprotein cholesterol levels and adverse clinical outcomes in chronic kidney disease: Results from the KNOW-CKD
Changhyun Lee, Jung Tak Park, Tae-Ik Chang, Ea Wha Kang, Ki Heon Nam, Young Su Joo, Su-Ah Sung, Yeong Hoon Kim, Dong-Wan Chae, Su Kyung Park, Curie Ahn, Kook-Hwan Oh, Tae-Hyun Yoo, Shin-Wook Kang, Seung Hyeok Han
Nutrition, Metabolism and Cardiovascular Diseases.2022; 32(2): 410. CrossRef Polypharmacy and the Progression of Chronic Kidney Disease: Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease
Hyang Ki Min, Su Ah Sung, Wookyung Chung, Yeong Hoon Kim, Dong-Wan Chae, Curie Ahn, Kook-Hwan Oh, Sue K. Park, Sung Woo Lee
Kidney and Blood Pressure Research.2021; 46(4): 460. CrossRef Predictive Model and Risk Factors for Case Fatality of COVID-19: A Cohort of 21,392 Cases in Hubei, China
Ran Wu, Siqi Ai, Jing Cai, Shiyu Zhang, Zhengmin (Min) Qian, Yunquan Zhang, Yinglin Wu, Lan Chen, Fei Tian, Huan Li, Mingyan Li, Hualiang Lin
The Innovation.2020; 1(2): 100022. CrossRef
|